-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $36

Benzinga·07/29/2026 10:23:41
Listen to the news
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $30 to $36.